Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Computed Tomography (CT) in Head and Neck Patients

This study has been terminated.
(insufficient recruitment)
Sponsor:
Information provided by:
University Health Network, Toronto
ClinicalTrials.gov Identifier:
NCT00188656
First received: September 12, 2005
Last updated: December 14, 2010
Last verified: December 2010
  Purpose

This study is conducting a comparison of chest x-ray (CXR) and minimum dose thoracic CT (MnDCT) in the detection of lung nodules (metastases) in patients with head and neck carcinoma.


Condition Intervention Phase
Lung Tumors
Procedure: CT thorax
Phase 1

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Minimum Dose CT in the Detection of Lung Nodules in Patients With Head and Neck Cancer

Further study details as provided by University Health Network, Toronto:

Primary Outcome Measures:
  • Detection of lung metastases

Estimated Enrollment: 100
Study Start Date: August 2003
Estimated Study Completion Date: September 2006
Detailed Description:

A comparison of chest x-ray (CXR) and minimum dose thoracic CT (MnDCT)in the detection of lung nodules (metastases) in patients with head and neck carcinoma

  Eligibility

Ages Eligible for Study:   16 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients with squamous cell carcinoma of the head and neck

Exclusion Criteria:

  • None
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00188656

Locations
Canada, Ontario
Princess Margaret Hospital
Toronto, Ontario, Canada
Sponsors and Collaborators
University Health Network, Toronto
Investigators
Principal Investigator: Narinder Paul, FRCP C University Health Network, Toronto
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00188656     History of Changes
Other Study ID Numbers: 03-0467
Study First Received: September 12, 2005
Last Updated: December 14, 2010
Health Authority: Canada: Health Canada

ClinicalTrials.gov processed this record on November 25, 2014